EVIDENCE WATCH
A review and assessment of recent clinical trial data

Breast cancer
REPRODUCIBILITY OF SEVERAL GENE EXPRESSION SIGNATURES IN PREDICTING OUTCOME IN BREAST CANCER.

EXPRESSION OF THE 21 GENES IN THE RECURRENCE SCORE ASSAY AND PREDICTION OF CLINICAL BENEFIT FROM TAMOXIFEN IN NSABP STUDY B-14 AND CHEMOTHERAPY IN NSABP STUDY B-20.

 

To view the clinical trial data of the above topics click here (pdf format)
Back to Top of Page 

 

 
 
 
Oncology Exchange provides overviews of important clinical trial data originally presented at the 27TH San Antonio Breast Cancer Symposium (SABCS), December 8–11, 2004. Leading Canadian experts offer commentary and clinical interpretations.
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
 Site created by Spin Design (514) 995-4398